Pantec raises $19.1 million

Pantec Biosolutions AG (Ruggell, Liechtenstein) raised CHF20 million ($19.1 million) through two undisclosed financing rounds led by new investor StemCell Holding. Pantec is developing its P.L.E.A.S.E. drug delivery technology for needle-free and painless administration of biopharmaceutical products. The company has two P.L.E.A.S.E. products in Phase II testing for in vitro fertilization. ...